Why medical care costs in Japan have increased despite declining prices for pharmaceuticals

Naoki Ikegami

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Analysis of the 1979 to 1993 surveys of national claims data shows that, using deflated prices, most of the increase in outpatient care costs is due to drugs, with increases in gross volume and deflated unit prices making equal contributions. Further analysis of detailed prescriptions data obtained from one-tenth of the total sample for 1991 and 1993 reveals that new drugs and originator drugs tend to be selected more often. The present vicious cycle of high launch prices, followed by subsequent cuts in the fee schedule, has led to adverse consequences for the industry, physicians and patients.

Original languageEnglish
Pages (from-to)97-105
Number of pages9
JournalPharmacoEconomics
Volume14
Issue numberSUPPL. 1
Publication statusPublished - 1998

Fingerprint

Health Care Costs
Japan
Fee Schedules
Pharmaceutical Preparations
Ambulatory Care
Prescriptions
Industry
Physicians
Costs and Cost Analysis
Surveys and Questionnaires

ASJC Scopus subject areas

  • Pharmacology
  • Medicine (miscellaneous)

Cite this

Why medical care costs in Japan have increased despite declining prices for pharmaceuticals. / Ikegami, Naoki.

In: PharmacoEconomics, Vol. 14, No. SUPPL. 1, 1998, p. 97-105.

Research output: Contribution to journalArticle

@article{e47c8afcc93345ee8e8cf673ca07aedb,
title = "Why medical care costs in Japan have increased despite declining prices for pharmaceuticals",
abstract = "Analysis of the 1979 to 1993 surveys of national claims data shows that, using deflated prices, most of the increase in outpatient care costs is due to drugs, with increases in gross volume and deflated unit prices making equal contributions. Further analysis of detailed prescriptions data obtained from one-tenth of the total sample for 1991 and 1993 reveals that new drugs and originator drugs tend to be selected more often. The present vicious cycle of high launch prices, followed by subsequent cuts in the fee schedule, has led to adverse consequences for the industry, physicians and patients.",
author = "Naoki Ikegami",
year = "1998",
language = "English",
volume = "14",
pages = "97--105",
journal = "PharmacoEconomics",
issn = "1170-7690",
publisher = "Adis International Ltd",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Why medical care costs in Japan have increased despite declining prices for pharmaceuticals

AU - Ikegami, Naoki

PY - 1998

Y1 - 1998

N2 - Analysis of the 1979 to 1993 surveys of national claims data shows that, using deflated prices, most of the increase in outpatient care costs is due to drugs, with increases in gross volume and deflated unit prices making equal contributions. Further analysis of detailed prescriptions data obtained from one-tenth of the total sample for 1991 and 1993 reveals that new drugs and originator drugs tend to be selected more often. The present vicious cycle of high launch prices, followed by subsequent cuts in the fee schedule, has led to adverse consequences for the industry, physicians and patients.

AB - Analysis of the 1979 to 1993 surveys of national claims data shows that, using deflated prices, most of the increase in outpatient care costs is due to drugs, with increases in gross volume and deflated unit prices making equal contributions. Further analysis of detailed prescriptions data obtained from one-tenth of the total sample for 1991 and 1993 reveals that new drugs and originator drugs tend to be selected more often. The present vicious cycle of high launch prices, followed by subsequent cuts in the fee schedule, has led to adverse consequences for the industry, physicians and patients.

UR - http://www.scopus.com/inward/record.url?scp=0031828728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031828728&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 97

EP - 105

JO - PharmacoEconomics

JF - PharmacoEconomics

SN - 1170-7690

IS - SUPPL. 1

ER -